DiaMedica Therapeutics Inc. announced the appointment of Julie VanOrsdel Daves, MSHS, CCRP, as Senior Vice President (SVP), Clinical Development Operations. Ms. Daves, a recognized leader in managing global clinical studies, has significant experience in all phases of clinical development and will complement DiaMedica's growing clinical team. Ms. Daves most recently served as a consultant to DiaMedica and as Vice President and Global Head, Clinical Operations at Sanifit, which was recently acquired by CSL in January 2022.

Prior roles include leadership positions in clinical operations at Edgewise Therapeutics, miRagen Therapeutics, Chiltern, Array Biopharma, and BioCryst Pharmaceuticals. Julie has a broad range of experience from Phase 1a (first-in-human) through Phase 3 registrational studies, including renal, dermatology, arthritis, oncology, autoimmune and neuromuscular disease, and vaccine development. Ms. Daves is a certified clinical research professional and received her MSHS in Clinical Research Administration from The George Washington University School of Medicine and Health Sciences and BS in Zoology from North Carolina State University.